Serum phosphohexose isomerase levels in patients with head and neck cancer
- 1 May 1986
- journal article
- research article
- Published by Cambridge University Press (CUP) in The Journal of Laryngology & Otology
- Vol. 100 (5) , 581-586
- https://doi.org/10.1017/s0022215100099692
Abstract
Serum phosphohexose isomerase (PHI) levels were estimated in 28 patients with head and neck cancer. The mean value was significantly higher when compared to the controls. There was no difference in mean PHI value with respect to the character of the lesion or with the histopathological type of growth. The activity was increased with the advancement of the stage of cancer.With radiotherapy, a gradual and significant decrease in serum PHI activity was observed.Keywords
This publication has 7 references indexed in Scilit:
- Enzymatic study in diagnosis of head and neck cancerIndian Journal of Otolaryngology and Head & Neck Surgery, 1979
- [99] Phosphohexose isomerase: Clinical aspectsPublished by Elsevier ,1966
- The value of serum phosphohexose isomerase as an index of metastatic breast carcinoma activityCancer, 1963
- Serum enzymes in disease. X. Glycolytic and oxidative enzymes and transaminases in patients with carcinoma of the head, neck, and esophagusCancer, 1962
- Serum Glycolytic Enzymes and Acid Phosphatases in Mammary CarcinomatosisBMJ, 1962
- Serum enzymes in disease.VIII. Glycolytic and oxidative enzymes and transaminases in patients with gastrointestinal carcinomaCancer, 1962
- Serum Isomerase in LeukemiaBritish Journal of Cancer, 1956